Type 1 diabetes (T1D) occurs when the immune system inappropriately attacks cells in the pancreas. Although many of the proteins attacked during T1D have been identified, it has not been determined whether immune responses to the individual proteins develop independently or whether a response to one protein then spreads to others. Now, a new study shows that in mice the immune system first attacks a single protein and then expands its attack to other proteins.
Using mice that develop a disease very similar to T1D (NOD mice), Thomas Kay and colleagues showed that NOD mice that were unable to mount an immune response to proinsulin also had no immune cells that recognized a second protein IGRP and did not develop diabetes.
By contrast, NOD mice that were unable to mount an immune response to IGRP had immune cells that recognize proinsulin and developed diabetes. This study demonstrates that diabetes in NOD mice is triggered by an immune response to a single protein that then spreads to other proteins. This study therefore has important implications for the development of therapeutics designed to make individuals with T1D no longer mount an immune response to a particular protein.
In an accompanying commentary, Lucienne Chatenoud and Sylvaine You from the Hôpital Necker-Enfants Malades, France, discuss how it is important to determine the molecular and cellular events that underlie this spreading of the immune response so that the information can be translated to therapeutics for T1D and perhaps other autoimmune diseases.
Source: Journal of Clinical Investigation
Related stories:
Scientists discover crucial control in long-lasting immunity
National Institutes of Health (NIH) scientists have identified a protein that plays matchmaker between two key types of white blood cells, T and B cells, enabling them to interact in a way that is crucial to establishing long-lasting immunity after an infection. Their finding may also explain why some individuals who have a genetic defect that prevents them from making this protein—called SAP—suffer from lethal infections with a common virus that otherwise is rarely fatal (Epstein-Barr virus), while others with this genetic defect have problems with B-cell lymphomas.
RNA molecules boost vaccine effectiveness
(PhysOrg.com) -- A novel delivery system that could lead to more efficient and more disease-specific vaccines against infectious diseases has been developed by biomedical engineers at The University of Texas at Austin.
Killing 'angry' immune cells in fat could fight diabetes
By killing off "angry" immune cells that take up residence in obese fat and muscle tissue, researchers have shown that they can rapidly reverse insulin resistance in obese mice. The findings reported in the October
Cell Metabolism, a publication of Cell Press, suggest that treatments aimed at specific subsets of the so-called macrophage cells might offer a very effective new antidiabetic therapy, according to the researchers.
Study links 'hygiene hypothesis' to diabetes prevention
A research study funded by JDRF suggests that a common intestinal bacteria may provide some protection from developing type 1 diabetes. The findings provide an important step towards understanding how and why type 1 diabetes develops in people, and may lead to potential cures.
Researchers develop novel anti-tumor vaccine
A novel anti-tumor vaccine for
neuroblastoma and melanoma developed by scientists and clinicians at Children's National Medical Center in collaboration with investigators from the University of Iowa is showing significant impact on tumor growth in mice, according to new research published in the October edition of the research journal
Cancer Immunology, Immunotherapy. The vaccine uses the tumor's own protein to induce an immune system response, allowing for a personalized approach to treatment.
Too many calories send the brain off kilter
An overload of calories throws critical portions of the brain out of whack, reveals a study in the October 3rd issue of the journal
Cell, a Cell Press publication. That response in the brain's hypothalamus—the "headquarters" for maintaining energy balance -- can happen even in the absence of any weight gain, according to the new studies in mice.
New way to control protein activity could lead to cancer therapies
Investigators at the Stanford University School of Medicine have found a way to quickly and reversibly fine-tune the activity of individual proteins in cells and living mammals, providing a powerful new laboratory tool for identifying — more precisely than ever before — the functions of different proteins.
Researchers discover new drug target for inflammatory disease
UC Davis researchers have defined a cellular process that promotes inflammation and, at the same time, found an important starting point for identifying and testing new drugs for diseases such as sepsis, rheumatoid arthritis, cardiovascular disease and some cancers.